期刊文献+

快速免疫组化法测定C-MET蛋白预测甲状腺癌颈淋巴结转移的意义 被引量:1

Expression of C-MET in thyroid carcinoma detected by rapid immunohistochemical analysis and its clinical significance for predicting lymph node metastases
原文传递
导出
摘要 目的探讨C-MET蛋白在甲状腺乳头状癌中的表达对甲状腺癌有无颈淋巴结转移的预测价值。方法采用术中快速免疫组化法检测85例甲状腺乳头状癌的C-MET表达,以期了解颈部淋巴结的转移情况。所有患者均行颈部淋巴结功能性清扫,比较C-MET蛋白两种染色强度的淋巴结转移率。结果染色强阳性25例,染色阳性60例。染色强阳性组淋巴结转移率明显高于染色阳性组(P<0.001)。结论 C-MET的表达是甲状腺乳头状癌是否有淋巴结转移的预测因子。术中快速免疫组化检查对决定是否行淋巴结清扫有一定的指导意义。 Objective To investigate expression of C-MET in palliary thyroid carcinoma(PTC) detected by rapid immunohistochemical analysis and its clinical significance to predicting lymph node metastases.Methods The expression level of C-MET was examined by rapid immunohistochemical analysis with C-MET-EPOS antibody in 85 cases of PTC.Results The rate of cervical lymph node metastates in PTC with strong positive stain expression(95.0%,23/25) was significantly higher than in PTC with positive stain expression(13.4%,8/60)(P〈0.001).Conclusions Intense c-Met expression is an indicator of the presence of the cervical lymph node metastases.C-Met expression by rapid immunohistochemical analysis is a significant indicator for estimation of cervical lymph node metastates and choice of operative methods.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2010年第5期471-474,共4页 China Journal of General Surgery
关键词 甲状腺肿瘤 腺癌 乳头状 C-MET 颈部淋巴结转移 快速免疫组化 Thyroid Neoplasms Adenocarcinoma Papillary C-MET Cervical Lymph Node Metastases Ripid Immunohistochemical Analysis
  • 相关文献

参考文献22

  • 1Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product[J]. Science, 1991,251(1) :802-804.
  • 2Di Renzo MF, Olivero M, Giacomini A, et al. Overexpression and amplification of the mct/HGF receptor gene during the progression of colorectal cancer [ J ]. Clin Cancer Res, 1995,1(3) :147 - 154.
  • 3Di Renzo MF, Olivero M, Katsaros D, et al. Overexpression of the Met/HGF receptor in ovarian cancer [ J ] . Int J Cancer, 1994,58(5) :658 -662.
  • 4Di Renzo MF, Poulsom M, Olivero M, et al. Expression of the Met/hepatoeyte growth factor receptor in human pancreatic cancer [J]. Cancer Res, 1995,55 (6) :1129 -1138.
  • 5Ichimura E, Maeshima A, Nakajima T, et al. Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivu and its prognostic significance [ J ]. Jpn J Cancer Res, 1996,87 (4) :1063 -1069.
  • 6Natali PG, Prat M, Nicotra MR, et al. Overexpression of the met/HGF receptor in renal cell carcinomas [ J ]. Int J Cancer,1996,69 (3) :212 -217.
  • 7Ponzetto C, Bardelli A, Zhen Z, et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family [ J ] . Cell, 1994,77 (3) :261 -271.
  • 8De Luca A, Arena N, Sena LM, et al. Met overexpression confers HGF-dependent invasive phenotype to human thyroid carcinoma cells in vitro [J]. J Cell Physiol, 1999,180 (3) :365 -371.
  • 9Giordano S, DiRenzo MF, Narsimhan RP, et al. Biosynthesis of the protein encoded by the c-met proto-oncogene [J]. Oneogene, 1989,4 (2) :1383 -1388.
  • 10Schlumberger MF. Papillary and follicular thyroid carcinoma [J].N Engl J Med, 1998,338 (5) :297 -306.

二级参考文献10

  • 1Ruco LP, Ranalli T, Marzullo A, et al. Expression of met protein in thyroid tumors[J]. J Pathol. 1996,180(5) :266 -270.
  • 2Belfiore A, Gangemi P, Constantino A, et al. Negative/low expression of the met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases[J] .J Clin Endocrinol Metab, 1997,82(6) :2322 -2328.
  • 3.
  • 4Ippolito A, Vella V, La Rosa GL, et al. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy[J].Thyroid, 2001 ,11(8) :783 -787.
  • 5.
  • 6Ponzetto C, Bardelli A, Zhen Z, et al. A muhifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family [ J ]. Cell, 1994,77(2) :261 -271.
  • 7De Luca A, Arena N, Sena LM, et al. MET overexpression confers HGF-dependent invasive phenotype to human thyroid carcinoma cells in vitro[J]. J Cell Physiol, 1999,180(9) :365-371.
  • 8Giordano S, DiRenzo MF, Narsimhan RP, et al. Biosynthesis of the protein encoded by the C-MET proto-oncogene [ J ]. Oncogene, 1989,4(2) :1383 - 1388.
  • 9Ramirez R,Hsu D,Patel A, et al. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor ( C- MET ) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma[J]. Clin Endocrinol, 2000,53(4) :635 -644.
  • 10Chen BK, Ohtsuki Y, Furihata M, et al. Overexpression of C-Met protein in human tumors correlated with lymph node metastases and clinicopathologic stage [ J ] . Pathol Res Pract. 1999 , 195(3) :427 -433.

共引文献4

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部